Agmatine ameliorates diabetes type 2-induced nephropathy in rats

Objective: To assess the nephroprotective potential of agmatine in a rat model of streptozotocin-induced diabetic nephropathy. Methods: A single dose of streptozotocin (40 mg/kg) coupled with a fructose diet induced diabetes in Wistar rats. Agmatine (40 and 80 mg/kg) was administered to rats for 12...

Full description

Bibliographic Details
Main Authors: Fatemah O Kamel, Ohoud Shagroud, Mai A.Alim A.Sattar Ahmad, Gamal S Abd El-Aziz, Abdulhadi S Burzangi, Duaa Bakhshwin, Maha Jamal, Shahid Karim
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Asian Pacific Journal of Tropical Biomedicine
Subjects:
Online Access:http://www.apjtb.org/article.asp?issn=2221-1691;year=2024;volume=14;issue=1;spage=8;epage=16;aulast=Kamel
_version_ 1797246472828223488
author Fatemah O Kamel
Ohoud Shagroud
Mai A.Alim A.Sattar Ahmad
Gamal S Abd El-Aziz
Abdulhadi S Burzangi
Duaa Bakhshwin
Maha Jamal
Shahid Karim
author_facet Fatemah O Kamel
Ohoud Shagroud
Mai A.Alim A.Sattar Ahmad
Gamal S Abd El-Aziz
Abdulhadi S Burzangi
Duaa Bakhshwin
Maha Jamal
Shahid Karim
author_sort Fatemah O Kamel
collection DOAJ
description Objective: To assess the nephroprotective potential of agmatine in a rat model of streptozotocin-induced diabetic nephropathy. Methods: A single dose of streptozotocin (40 mg/kg) coupled with a fructose diet induced diabetes in Wistar rats. Agmatine (40 and 80 mg/kg) was administered to rats for 12 weeks. The body weight and fasting blood glucose were measured weekly. Insulin level, urine output, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C were also determined at the end of the experiment. Furthermore, superoxide dismutase, glutathione, interleukin-1β, interleukin-6, and tumor necrosis factor-alpha were evaluated in kidney tissue. Histopathological study was also performed using hematoxylin and eosin staining. Results: Agmatine at both doses significantly increased final body weight, and lowered fasting blood glucose, urine output, insulin, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C levels compared with the diabetic group (P < 0.05). Inflammatory markers and antioxidant effect were significantly improved in agmatine-treated rats. Moreover, the histopathological changes in renal structure were ameliorated by agmatine treatment. Conclusions: Agmatine alleviates diabetic nephropathy by improving renal functions and reducing inflammation and oxidative stress. The molecular mechanisms of its nephroprotective actions need to be investigated in future study.
first_indexed 2024-04-24T19:43:21Z
format Article
id doaj.art-b83d1f9b0f7e42dfb2db41f787a82185
institution Directory Open Access Journal
issn 2221-1691
2588-9222
language English
last_indexed 2024-04-24T19:43:21Z
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Pacific Journal of Tropical Biomedicine
spelling doaj.art-b83d1f9b0f7e42dfb2db41f787a821852024-03-25T10:07:16ZengWolters Kluwer Medknow PublicationsAsian Pacific Journal of Tropical Biomedicine2221-16912588-92222024-01-0114181610.4103/2221-1691.393580Agmatine ameliorates diabetes type 2-induced nephropathy in ratsFatemah O KamelOhoud ShagroudMai A.Alim A.Sattar AhmadGamal S Abd El-AzizAbdulhadi S BurzangiDuaa BakhshwinMaha JamalShahid KarimObjective: To assess the nephroprotective potential of agmatine in a rat model of streptozotocin-induced diabetic nephropathy. Methods: A single dose of streptozotocin (40 mg/kg) coupled with a fructose diet induced diabetes in Wistar rats. Agmatine (40 and 80 mg/kg) was administered to rats for 12 weeks. The body weight and fasting blood glucose were measured weekly. Insulin level, urine output, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C were also determined at the end of the experiment. Furthermore, superoxide dismutase, glutathione, interleukin-1β, interleukin-6, and tumor necrosis factor-alpha were evaluated in kidney tissue. Histopathological study was also performed using hematoxylin and eosin staining. Results: Agmatine at both doses significantly increased final body weight, and lowered fasting blood glucose, urine output, insulin, total protein, albumin, blood urea nitrogen, creatinine, and cystatin-C levels compared with the diabetic group (P < 0.05). Inflammatory markers and antioxidant effect were significantly improved in agmatine-treated rats. Moreover, the histopathological changes in renal structure were ameliorated by agmatine treatment. Conclusions: Agmatine alleviates diabetic nephropathy by improving renal functions and reducing inflammation and oxidative stress. The molecular mechanisms of its nephroprotective actions need to be investigated in future study.http://www.apjtb.org/article.asp?issn=2221-1691;year=2024;volume=14;issue=1;spage=8;epage=16;aulast=Kamelagmatine; type 2 diabetes; nephropathy; oxidative stress; nephroprotection
spellingShingle Fatemah O Kamel
Ohoud Shagroud
Mai A.Alim A.Sattar Ahmad
Gamal S Abd El-Aziz
Abdulhadi S Burzangi
Duaa Bakhshwin
Maha Jamal
Shahid Karim
Agmatine ameliorates diabetes type 2-induced nephropathy in rats
Asian Pacific Journal of Tropical Biomedicine
agmatine; type 2 diabetes; nephropathy; oxidative stress; nephroprotection
title Agmatine ameliorates diabetes type 2-induced nephropathy in rats
title_full Agmatine ameliorates diabetes type 2-induced nephropathy in rats
title_fullStr Agmatine ameliorates diabetes type 2-induced nephropathy in rats
title_full_unstemmed Agmatine ameliorates diabetes type 2-induced nephropathy in rats
title_short Agmatine ameliorates diabetes type 2-induced nephropathy in rats
title_sort agmatine ameliorates diabetes type 2 induced nephropathy in rats
topic agmatine; type 2 diabetes; nephropathy; oxidative stress; nephroprotection
url http://www.apjtb.org/article.asp?issn=2221-1691;year=2024;volume=14;issue=1;spage=8;epage=16;aulast=Kamel
work_keys_str_mv AT fatemahokamel agmatineamelioratesdiabetestype2inducednephropathyinrats
AT ohoudshagroud agmatineamelioratesdiabetestype2inducednephropathyinrats
AT maiaalimasattarahmad agmatineamelioratesdiabetestype2inducednephropathyinrats
AT gamalsabdelaziz agmatineamelioratesdiabetestype2inducednephropathyinrats
AT abdulhadisburzangi agmatineamelioratesdiabetestype2inducednephropathyinrats
AT duaabakhshwin agmatineamelioratesdiabetestype2inducednephropathyinrats
AT mahajamal agmatineamelioratesdiabetestype2inducednephropathyinrats
AT shahidkarim agmatineamelioratesdiabetestype2inducednephropathyinrats